相关实验视频

Updated: Jan 7, 2026

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

抗体 - 药物结合物及其他:为乳腺癌提供下一代向治疗方法

Adil Farooq Wali¹, Mohamed El-Tanani¹, Sirajunisa Talath¹

¹RAK College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates.

|December 30, 2025

概括

抗体-药物合物 (ADCs) 正在通过精确向癌细胞来彻底改变乳腺癌治疗. 最近的进展表明,生存率有所提高,特别是在HER2-低和三阴性乳腺癌 (TNBC) 亚型中.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
生物技术是生物技术.

背景情况:

乳腺癌是全球癌症相关死亡的主要原因之一.
抗体与药物合物 (ADC) 通过将抗体与细胞毒药物结合,提供向治疗.
现有的ADC主要向HER2 (人类表皮生长因子受体2),具有显著的临床成功.

研究的目的:

审查乳腺癌治疗的ADC最近的进展.
为了突出下一代的ADCs超越HER2向剂.
讨论ADC治疗中的机制,技术和临床发展.

主要方法:

对乳腺癌中ADCs的系统文献综述.
对ADC结构部件 (抗体,链接器,有效载荷) 的分析.
对各种乳腺癌亚型的临床前发现和临床证据的整合.

主要成果:

像trastuzumab emtansine (T-DM1) 和trastuzumab deruxtecan (T-DXd) 这样的ADCs显著改善了无进展和整体存活率.
ADCs在HER2阳性,HER2低和三阴性乳腺癌 (TNBC) 中表现出有效性.
新兴的ADC针对HER3 (人类表皮生长因子受体3) 和Nectin-4,以及双特异性和免疫刺激方法.

结论:

ADCs代表了乳腺癌精密瘤学的范式转变.
新的ADC设计和目标通过克服耐药性和降低毒性提供了更好的结果.
未来的机遇在于为各种乳腺癌亚型设计更有选择性和更有效的ADC平台.

关键词:

在HER2中,HER2是HER2.抗体药物联合体抗体药物联合体乳腺癌乳腺癌乳腺癌精确瘤学精确瘤学有针对性的治疗.这就是特拉斯图祖马布 (trastuzumab).

更多相关视频

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...